Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 11, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2021. Go to the latest filing (Q3 2026)

10.1B USDQ4 2021
Total value of stock positions
10.1B USD
Positions
53
Share of the ten largest
66.3%

The ten largest positions Q4 2021

  1. Liberty Global PLC 15.0%unchanged
  2. Qorvo Inc 9.2%▲ +16.9%
  3. Intel 9.2%▼ −8.7%
  4. Viasat Inc 7.2%unchanged
  5. Alphabet Inc. (Class C) 6.5%▼ −21.6%
  6. Liberty Media Corp Del 5.3%▲ +15.7%
  7. Veritiv Corp 4.3%unchanged
  8. Meta Platforms 3.3%▼ −36.4%
  9. Fiserv 3.1%new
  10. SS&C Technologies HLDGS Inc 3.1%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q4 2021

Positions Q4 2021 per 13F filing, 11 of 11
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
EBAY eBay Inc. 3.8% 5,982,667 416.8M USD sold out
Shaw Communications Inc 2.0% 7,530,807 218.7M USD sold out
IFF International Flavors & Fragrances 1.5% 1,242,483 166.1M USD sold out
PCG PG&E Corporation 0.6% 7,216,458 69.3M USD sold out
Horizon Acquisition Corporat 0.3% 3,499,998 34.3M USD sold out
Broadstone Acquisition Corp 0.3% 2,970,000 29.6M USD sold out
Investindustrial Acquisition 0.2% 2,100,000 20.9M USD sold out
Dragoneer Growth Oppty Corp < 0.1% 1,000,000 10.0M USD sold out
Broadstone Acquisition Corp < 0.1% 1,485,000 1.6M USD sold out
Reinvent Technology Partners < 0.1% 750,000 1.1M USD sold out
Investindustrial Acquisition < 0.1% 700,000 903.0K USD sold out
Plus 1 position in convertible bonds and bonds worth 28.8M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 28.8M USD

Breakdown by sector

  • Technology 13.7%
  • Communication Services 9.8%
  • Financials 6.1%
  • Industrials 0.7%
  • not in our coverage 69.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close